North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026

The North America Cough Syrup Market is expected to witness market growth of 4.5% CAGR during the forecast period (2020-2026).

Cough syrups witnesses a surge in demand due to their wide usage for curing common cold, URTI, and hay fever. Moreover, the increasing disposable income of people in emerging nations will also contribute to the rising growth of the global cough syrups market. In addition, the growing geriatric population will also open various growth prospects for the market.

These cough syrups are prescribed by doctors which are consumed by patients having symptoms like runny nose, common cold, sneezing, and some respiratory infections. In the covid-19 pandemic, people who get infected by the virus shows certain symptoms, among which cough & common cold is the most common one. Many doctors & scientists stated that cough syrup has pro-viral properties which are not good for people who get infected by covid-19.

The increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market. Moreover, the rising population of old age people along with increasing air pollution are driving the growth of the market. However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth. On the other hand, the high market potential of the developing regions will garner more growth opportunities for the cough syrup market growth.

The US market dominated the North America Combination Medications Market by Country in 2019, and is expected to continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 5.2% during (2020 - 2026). Additionally, The Mexico market is expected to witness a CAGR of 4.3% during (2020 - 2026).

The Adult market dominated the Canada Cough Syrup Market by Age Group in 2019, thereby, achieving a market value of $195.9 million by 2026. Additionally, The Pediatric market is expected to witness highest CAGR of 8.1% during (2020 - 2026).

Based on Product, the market is segmented into Cough Suppressants, Combination Medications and Expectorants. Based on Age Group, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).

Scope of the Study

Market Segments covered in the Report:

By Product

• Cough Suppressants
• Combination Medications
• Expectorants

By Age Group

• Adult
• Pediatric

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• Pfizer, Inc.
• Novartis AG
• Merck Group
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• The Procter and Gamble Company
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Sanofi S.A.
• Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC)

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free